AI
ANGO icon

Acuitas Investments’s AngioDynamics ANGO Stock Holding History

Acuitas Investments’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-498,530
Closed -$5.57M – 5
2025
Q3 		$5.57M Buy
498,530
+56,300
+13% +$543K 3.57% 5
2025
Q2 		$4.39M Hold
442,230
– – 3.49% 9
2025
Q1 		$4.15M Buy
442,230
+38,950
+10% +$409K 3.54% 6
2024
Q4 		$3.69M Hold
403,280
– – 3.03% 9
2024
Q3 		$3.14M Hold
403,280
– – 1.4% 24
2024
Q2 		$2.44M Hold
403,280
– – 1.31% 26
2024
Q1 		$2.37M Hold
403,280
– – 1.19% 35
2023
Q4 		$3.16M Buy
403,280
+31,480
+8% +$218K 1.65% 17
2023
Q3 		$2.72M Hold
371,800
– – 1.6% 19
2023
Q2 		$3.88M Buy
+371,800
New +$3.58M 2.26% 12

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KK
Kotler Kevin $427M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Acuitas Investments's ANGO Position: Q4 2025 in Review

Acuitas Investments sold out of AngioDynamics (ANGO) in Q4 2025, closing a stake of 498,530 shares — an estimated $5.57M sold.

Acuitas Investments first reported a position in ANGO in Q2 2023 and held it in 10 quarters. The position peaked at $5.57M in Q3 2025. 167 funds tracked by Wall St. Rank hold ANGO as of Q4 2025.

  • Acuitas Investments reported no remaining AngioDynamics position as of Q4 2025 after selling out during the quarter.
  • Acuitas Investments sold 498,530 AngioDynamics shares in Q4 2025, an estimated $5.57M.
  • Acuitas Investments first reported a position in AngioDynamics in Q2 2023 and held it in 10 quarters.
  • Acuitas Investments's AngioDynamics position peaked at $5.57M in Q3 2025.
  • 167 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2025.

Based on Acuitas Investments's 13F filing for Q4 2025, filed 27 Jan 2026.